Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta-arrestin recruitment refers to the process by which beta-arrestins (β-arrestin 1 and β-arrestin 2) are recruited to activated G protein-coupled receptors (GPCRs) at the cell membrane. This event is a key step in both terminating G protein signaling and initiating alternative signaling pathways independent of G proteins. Beta-arrestins act as adaptors, facilitating receptor desensitization, internalization, and scaffolding of signaling complexes.
Beta-arrestins bind phosphorylated GPCRs, sterically hindering G protein coupling and initiating alternative signaling pathways. They also promote receptor endocytosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-arrestin Recruitment (None).